Business Model

The company implements a cost-effective competence strategy by recruiting core positions and consultants with documented expertise in their fields within business management, pharmaceutical development, clinical trials, regulatory procedure, licensing and patent applications.

This strategy ensures good flexibility in relation to continuously changing requirements for specialist expertise in the development of the company’s drug candidates. The company is furthermore implementing a proactive strategy in intellectual property in order to safeguard continual growth of the company’s portfolio value and promote the company’s position in future negotiations with partners.

Aptahem collaborates with academic groups around the world to develop the company’s drug candidates within as mabyt indications as possible, within the range of the candidates’ multi-mechanistic actions.